Investigating survival, quality of life and cognition in PROton versus photon therapy for IDH- mutated diffuse grade 2 and 3 GLIOmas (PRO-GLIO): a randomised controlled trial in Norway and Sweden.

Liv Cathrine HeggebøIda Maria Henriksen BorgenHillevi RylanderCecilie KiserudTonje Haug NordenmarkTaran Paulsen HellebustMorten Egeberg EvensenMagnus GustavssonChristina RambergMette SprautenHenriette MagelssenHanne BlakstadJanani MoorthyKarin AnderssonIngela RaunertThomas HenryCecilie MoeCarin GranlundDorota GoplenJorunn BrekkeTor-Christian Aase JohannessenTora Skeidsvoll SolheimKirsten MarienhagenØyvind HumbersetPer BergströmMåns AgrupLudvig DahlMichael GubanskiHelene GojonCarl-Johan BrahmeIsabelle RydénAsgeir S JakolaEinar O Vik-MoHanne C LieLars AsphaugMaziar HervaniIngrid KristensenCorina Silvia RueeggInge C OlsenRolf J LedalEskil DegsellKatja WerleniusMalin BlomstrandPetter Brandal

Published in: BMJ open (2023)

ClinicalTrials.gov Registry (NCT05190172).

Keyphrases

low grade
high grade
wild type
mild cognitive impairment
anti inflammatory
living cells
free survival
white matter
electron transfer
single molecule
fluorescent probe